RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 267 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2024. The put-call ratio across all filers is 2.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $308,272 | +138.6% | 30,920 | +136.0% | 0.00% | +100.0% |
| Q4 2023 | $129,205 | -95.2% | 13,104 | -96.8% | 0.00% | -94.1% |
| Q1 2023 | $2,712,435 | +120.1% | 406,662 | +154.4% | 0.02% | +142.9% |
| Q4 2022 | $1,232,312 | +3.8% | 159,833 | +43.3% | 0.01% | 0.0% |
| Q3 2022 | $1,187,000 | +521.5% | 111,575 | +376.7% | 0.01% | +600.0% |
| Q2 2022 | $191,000 | -69.9% | 23,408 | -73.6% | 0.00% | -80.0% |
| Q1 2022 | $635,000 | +9.7% | 88,748 | +162.7% | 0.01% | -16.7% |
| Q4 2021 | $579,000 | -9.1% | 33,777 | +22.0% | 0.01% | -25.0% |
| Q3 2021 | $637,000 | +28.4% | 27,686 | +103.6% | 0.01% | +33.3% |
| Q2 2021 | $496,000 | – | 13,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Sigma Ventures, LP | 903,400 | $9,612,000 | 100.00% |
| Obvious Management Services, L.L.C. | 3,985,087 | $42,401,000 | 100.00% |
| DCVC Opportunity Fund II GP, LLC | 3,951,141 | $42,040,000 | 54.37% |
| Data Collective IV GP, LLC | 5,941,120 | $63,214,000 | 49.97% |
| MIC Capital Management UK LLP | 8,451,758 | $89,927,000 | 16.21% |
| MV Management XI, L.L.C. | 1,971,908 | $20,981,000 | 15.20% |
| ArchPoint Investors | 1,116,126 | $11,876,000 | 4.85% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $16,058,000 | 2.00% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,251,971 | $23,961,000 | 1.00% |
| Duquesne Family Office | 1,385,950 | $14,747,000 | 0.84% |